What is the optimal timing to repeat a CT brain scan for a patient with acute ischemic stroke who is previously on apixaban (eliquis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing to Repeat CT Brain for Acute Ischemic Stroke Patients Previously on Apixaban

For acute ischemic stroke patients previously on apixaban, obtain a repeat CT brain scan at 24 hours after the initial stroke event, regardless of clinical stability, before initiating any anticoagulation or antiplatelet therapy for secondary stroke prevention. 1, 2

Standard 24-Hour Follow-Up Protocol

  • All acute ischemic stroke patients require a repeat CT or MRI brain scan at 24 hours after the initial stroke event, even if clinically stable. 1, 2
  • This 24-hour follow-up scan is mandatory before starting anticoagulants or antiplatelet agents for secondary stroke prevention. 1, 2
  • The follow-up imaging serves to detect hemorrhagic transformation, assess infarct progression, and confirm the diagnosis. 1, 2

If Thrombolysis Was Administered

  • The same 24-hour repeat imaging protocol applies to patients who received thrombolytic therapy. 1
  • Neurological assessments should be performed every 15 minutes during the tPA infusion, every 30 minutes for the next 6 hours, then hourly until 24 hours after treatment. 1
  • The 24-hour CT scan is required before starting anticoagulants or antiplatelet agents for secondary stroke prevention. 1

Emergency Repeat CT Indications

Obtain immediate repeat CT scanning for any neurological deterioration, regardless of the time since initial imaging. 3, 1, 2

  • Emergency repeat CT is indicated for:
    • Any decline in level of consciousness 1
    • Worsening NIHSS score by ≥4 points from baseline 1
    • New or worsening brainstem signs 3
    • Any neurological deterioration whatsoever 3, 1

Special Considerations for Patients Previously on Apixaban

  • Patients on anticoagulants like apixaban have a 3-fold increased risk of hemorrhage progression (26% vs 9%) compared to non-anticoagulated patients. 3
  • If the initial CT shows intracranial hemorrhage, plan for follow-up imaging within 24 hours to assess for hemorrhage progression. 3
  • The presence of any intracranial hemorrhage on initial CT requires neurosurgical consultation and consideration of anticoagulation reversal with andexanet alfa (specific reversal agent for apixaban) or prothrombin complex concentrate if unavailable. 3

Imaging Modality Selection

  • CT head without IV contrast is usually preferred for follow-up due to its quick repeatability and ease of comparison to prior examinations. 2
  • MRI is more accurate for detecting chronic intracerebral hemorrhage and small intraventricular hemorrhages but is not required for routine follow-up. 2
  • There is no role for IV contrast in CT evaluation of evolving or subacute infarct. 2

Common Pitfalls to Avoid

  • Do not delay the 24-hour follow-up CT scan, as this postpones initiation of secondary stroke prevention measures. 1, 2
  • Do not rely solely on clinical examination without follow-up imaging, as this may miss asymptomatic hemorrhagic transformation. 1
  • Do not delay emergency repeat imaging when neurological deterioration occurs, regardless of time since initial scan. 3, 1
  • Failing to consider the patient's anticoagulation status may lead to underestimating hemorrhage progression risk. 3

References

Guideline

CT Scan Timing and Expectations After Thrombolysis for Ischemic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Timing of Follow-up Imaging After Ischemic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Imaging Guidelines for Patients on Apixaban Anticoagulation with Head Trauma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management of a patient who experiences a stroke while on Eliquis (apixaban)?
What is the management approach for a patient who experiences a stroke while on apixaban (Apixaban is a Direct Oral Anticoagulant (DOAC))?
Is apixaban (eliquis) safe for patients with a history of hemorrhagic stroke?
What anticoagulant (blood thinner) options are recommended for patients with ischemic stroke, particularly those with atrial fibrillation?
Should a patient with atrial fibrillation (Afib) on apixaban (eliquis) who has experienced a cerebrovascular accident (CVA) be started on aspirin (acetylsalicylic acid, ASA)?
What is the preferred antibiotic, cephalexin or clindamycin, for a patient with a bacterial infection, considering potential allergies and impaired renal function?
What is the best treatment approach for an adult patient with hypersensitivity and atrial flutter, considering their potential history of cardiovascular disease?
When is nicardipine (calcium channel blocker) contraindicated in anesthesia, particularly in patients with severe aortic stenosis, cardiogenic shock, advanced heart failure with low output, cerebral vasospasm, or increased intracranial pressure?
What are urine catecholamine measurements used for in adults with symptoms like hypertension, palpitations, sweating, or headaches?
What is the recommended treatment for a patient with Cytomegalovirus (CMV) infection, particularly with valganciclovir (Valcyte)?
What is the best management approach for a 29-year-old male patient with metabolic risk factors, including obesity, elevated Low-Density Lipoprotein (LDL) cholesterol, and hypertriglyceridemia, who presents with persistent elevation of liver enzymes, hepatic steatosis, and a low risk of advanced fibrosis, as indicated by a FIB-4 (Fibrosis-4) score <1.3?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.